Document Detail


The mitotic checkpoint: a signaling pathway that allows a single unattached kinetochore to inhibit mitotic exit.
MedLine Citation:
PMID:  14593737     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The mitotic checkpoint is a failsafe mechanism for the cell to ensure accurate chromosome segregation during mitosis. Mutations in genes encoding essential checkpoint proteins lead to chromosome instability and promote carcinogenesis. The BUB and MAD genes are essential components of the mitotic checkpoint pathway. BUB and MAD inhibit the ubiquitin ligase activity of the Anaphase Promoting Complex/Cyclosome (APC/C) during mitosis to ensure cells with unaligned chromosomes do not prematurely enter anaphase. Two models explain how the APC/C is inhibited by the checkpoint. The Sequestration Model postulates that Mad2 and BubR1 bind and sequester Cdc20, an APC/C activator, away from APC/C so substrates whose destruction drives mitotic exit are no longer ubiquitinated. In this model, the unattached kinetochore is postulated to catalytically convert Mad2 to a form that binds Cdc20. In the Direct Inhibition Model, the Mitotic Checkpoint Complex (MCC) consisting of BubR1, Bub3, Mad2 and Cdc20 binds and inhibits the APC/C independently of the kinetochore. However, the "wait anaphase" signal generated by unattached kinetochores sensitizes the APC/C to prolonged inhibition by the MCC. A single unattached kinetochore is proposed to amplify the "wait anaphase" signal through a kinase cascade involving checkpoint kinases such as hBubR1, hBub1 and Mps1.
Authors:
Gordon K Chan; Tim J Yen
Related Documents :
14630067 - The impairments of neoblast division in regenerating planarian polycelis felina (daly.)...
15066637 - Spindle mechanics and dynamics during mitosis in drosophila.
17178907 - Katanin controls mitotic and meiotic spindle length.
16267267 - Different plk1 functions show distinct dependencies on polo-box domain-mediated targeting.
7172867 - The synaptonemal complexes of caenorhabditis elegans: pachytene karyotype analysis of m...
3467897 - The terminal deoxynucleotidyltransferase gene is located on human chromosome 10 (10q23-...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review    
Journal Detail:
Title:  Progress in cell cycle research     Volume:  5     ISSN:  1087-2957     ISO Abbreviation:  Prog Cell Cycle Res     Publication Date:  2003  
Date Detail:
Created Date:  2003-11-03     Completed Date:  2003-12-11     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  9609058     Medline TA:  Prog Cell Cycle Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  431-9     Citation Subset:  IM    
Affiliation:
Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada T6G 1Z2.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anaphase / genetics*
Animals
Calcium-Binding Proteins / genetics
Carrier Proteins*
Cell Cycle Proteins / genetics*
Fungal Proteins / genetics
Genes, cdc / physiology*
Humans
Kinetochores / physiology*
Mitosis / genetics*
Nuclear Proteins
Protein Kinases / genetics
Protein-Serine-Threonine Kinases
Signal Transduction / genetics*
Ubiquitin-Protein Ligase Complexes / genetics
Grant Support
ID/Acronym/Agency:
CA06927/CA/NCI NIH HHS; GM44762/GM/NIGMS NIH HHS; P01 CA75138/CA/NCI NIH HHS
Chemical
Reg. No./Substance:
0/Calcium-Binding Proteins; 0/Carrier Proteins; 0/Cell Cycle Proteins; 0/Fungal Proteins; 0/Nuclear Proteins; EC 2.7.-/Protein Kinases; EC 2.7.11.1/Bub1 spindle checkpoint protein; EC 2.7.11.1/Protein-Serine-Threonine Kinases; EC 6.3.2.19/Ubiquitin-Protein Ligase Complexes; EC 6.3.2.19/anaphase-promoting complex

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Inhibitors of the G2 DNA damage checkpoint and their potential for cancer therapy.
Next Document:  Interruption of tumor cell cycle progression through proteasome inhibition: implications for cancer ...